Healthcare provider profile · identity verified

Jill Simon, MD

Family Practice · MOSES LAKE, WA · NPI 1174606297

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	376	106
Levothyroxine Sodium	Levothyroxine Sodium	235	63
Losartan Potassium	Losartan Potassium	221	58
Amlodipine Besylate	Amlodipine Besylate	214	59
Lisinopril	Lisinopril	178	56
Rosuvastatin Calcium	Rosuvastatin Calcium	175	50
Hydrochlorothiazide	Hydrochlorothiazide	145	44
Omeprazole	Omeprazole	132	44
Metformin Hcl	Metformin Hcl	125	37
Furosemide	Furosemide	117	33
Gabapentin	Gabapentin	112	29
Metoprolol Succinate	Metoprolol Succinate	97	32
Trulicity	Dulaglutide	95	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	94	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	90	27
Potassium Chloride	Potassium Chloride	83	25
Albuterol Sulfate Hfa	Albuterol Sulfate	77	36
Jardiance	Empagliflozin	71	20
Venlafaxine Hcl Er	Venlafaxine Hcl	71	13
Citalopram Hbr	Citalopram Hydrobromide	68	16
Zolpidem Tartrate	Zolpidem Tartrate	68	11
Sertraline Hcl	Sertraline Hcl	61	17
Duloxetine Hcl	Duloxetine Hcl	56	16
Pregabalin	Pregabalin	52	13
Oxycodone Hcl	Oxycodone Hcl	51	11
Trazodone Hcl	Trazodone Hcl	49	suppressed
Eliquis	Apixaban	46	15
Famotidine	Famotidine	46	15
Alendronate Sodium	Alendronate Sodium	45	16
Metformin Hcl Er	Metformin Hcl	45	16
Metoprolol Tartrate	Metoprolol Tartrate	45	12
Pantoprazole Sodium	Pantoprazole Sodium	43	13
Glipizide	Glipizide	42	14
Bupropion Xl	Bupropion Hcl	40	suppressed
Carvedilol	Carvedilol	40	suppressed
Meloxicam	Meloxicam	40	12
Ezetimibe	Ezetimibe	39	12
Tramadol Hcl	Tramadol Hcl	39	suppressed
Januvia	Sitagliptin Phosphate	38	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	38	suppressed
Warfarin Sodium	Warfarin Sodium	38	suppressed
Fluticasone Propionate	Fluticasone Propionate	37	17
Solifenacin Succinate	Solifenacin Succinate	35	suppressed
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Memantine Hcl	Memantine Hcl	32	suppressed
Methocarbamol	Methocarbamol	32	12
Spironolactone	Spironolactone	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Ibuprofen	Ibuprofen	30	15
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Atenolol	Atenolol	28	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	27	27
Xarelto	Rivaroxaban	27	suppressed
Farxiga	Dapagliflozin Propanediol	26	suppressed
Humalog Kwikpen U-100	Insulin Lispro	26	suppressed
Ozempic	Semaglutide	25	suppressed
Torsemide	Torsemide	25	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Testosterone Cypionate	Testosterone Cypionate	23	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	11
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	21	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Topiramate	Topiramate	20	suppressed
Baclofen	Baclofen	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Prednisone	Prednisone	19	14
Clonidine Hcl	Clonidine Hcl	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Simvastatin	Simvastatin	18	suppressed
Allopurinol	Allopurinol	17	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	13
Fluconazole	Fluconazole	16	13
Oxycontin	Oxycodone Hcl	16	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	12
Fenofibrate	Fenofibrate	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Loxapine	Loxapine Succinate	14	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	14	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	14	11
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	11
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Lurasidone Hcl	Lurasidone Hcl	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Nystatin	Nystatin	11	suppressed
Trueplus Pen Needle	Pen Needle, Diabetic	11	suppressed
Uloric	Febuxostat	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error